SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

被引：0
|
作者：
Bussel, J. [1 ]
Tarantino, M. [2 ]
Blanchette, V. [3 ]
Raj, A. [4 ]
Despotovic, J. [5 ]
Beam, D. [6 ]
Roy, J. [7 ,8 ]
Wang, X. [9 ]
Mehta, B. [9 ]
Eisen, M. [9 ]
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[3] Hosp Sick Children, Toronto, ON, Canada
[4] Pediat Blood & Canc Disorders Clin, Louisville, KY USA
[5] Texas Childrens Hematol Ctr, Houston, TX USA
[6] Cook Childrens Med Ctr, Ft Worth, TX USA
[7] Childrens Hlth Queensland, St Lucia, Qld, Australia
[8] Pathol Queensland, St Lucia, Qld, Australia
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P727
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [31] Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): 3-Year Update from An Open-Label
    Kuter, Davrt J.
    Bussel, James B.
    Newland, Adrian
    de Wolf, Joost T. M.
    Guthrie, Troy
    Wasser, Jeffrey
    Gehl, Lara
    Nie, Kun
    Berger, Dietmar
    BLOOD, 2008, 112 (11) : 154 - 154
  • [32] LONGER-TERM USE OF THE THROMBOPOIETIN-MIMETIC PEPTIBODY ROMIPLOSTIM IN CHILDREN WITH CHRONIC/REFRACTORY IMMUNE THROMBOCYTOPENIA (ITP): RESULTS OF AN OPEN-LABEL EXTENSION STUDY
    Nugent, Diane
    Bussel, James
    Buchanan, George
    Stine, Kimo
    Kalpatthi, Ramasubramanian
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 916 - 916
  • [33] Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
    Bussel, James B.
    Kuter, David J.
    Pullarkat, Vinod
    Lyons, Roger M.
    Guo, Matthew
    Nichol, Janet L.
    BLOOD, 2009, 113 (10) : 2161 - 2171
  • [34] ROMIPLOSTIM: EFFICACY AND SAFETY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP). SINGLE CENTRE EXPERIENCE
    Zotova, I.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2014, 99 : 208 - 208
  • [35] Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Wasser, Jeffrey
    Godeau, Bertrand
    Provan, Andrew
    Lyons, Roger M.
    Altomare, Ivy
    Wang, Xuena
    Woodard, Paul
    BLOOD, 2012, 120 (21)
  • [36] Update of An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)
    Fenaux, Pierre
    Kantarjian, Hagop M.
    Muus, Petra
    Lyons, Roger M.
    Larson, Richard A.
    Sekeres, Mikkael A.
    Becker, Pamela S.
    Jia, Catherine
    Yang, Allen S.
    BLOOD, 2011, 118 (21) : 1193 - 1194
  • [37] An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients (Pts) with Myelodysplastic Syndromes (MDS).
    Fenaux, Pierre
    Kantarjian, Hagop
    Lyons, Roger
    Larson, Richard A.
    Sekeres, Mikkael A.
    Becker, Pamela S.
    Muus, Petra
    Hu, Kuolong
    Berger, Dietmar
    Franklin, Janet L.
    BLOOD, 2009, 114 (22) : 1081 - 1081
  • [38] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [39] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [40] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
12345